News

Risks of autoimmune conditions (ACs) in patients treated with immune checkpoint inhibitors (ICIs), a critical class of cancer immunotherapies, have been explored in a new epidemiological study.

A recent clinical trial has shown promising results in treating severe, active vitiligo through a combination of oral medication and phototherapy, offering new hope for managing this challenging condition.

A Phase II trial examining neoadjuvant therapy for difficult-to-resect cutaneous basal cell carcinoma (BCC) demonstrates promising outcomes.

In Nueces County, Texas, researchers uncovered troubling insights into dementia diagnosis awareness among a diverse population.

Financial barriers to asthma medications continue to compromise patient outcomes, increasing the risk of asthma attacks and emergency room visits, according to a recent analysis spanning 2011 to 2022.

Females are at significantly higher risk of developing long COVID compared to males, according to a recent cohort study involving over 12,000 participants.

Fixed-combination topical therapies show improvements in acne within the first 4 weeks of treatment, according to new data compiled from pivotal clinical trials.

New research published highlights a potential link between anti-inflammatory treatments and a reduced risk of Parkinson’s disease (PD) in patients with autoimmune disorders.